Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 549174, 12 pages
http://dx.doi.org/10.1155/2013/549174
Review Article

Botanical Compounds: Effects on Major Eye Diseases

1Department of Ophthalmology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
2Dean A. McGee Eye Institute, 608 Stanton L Young Boulevard, Oklahoma City, OK 73104, USA
3College of Public Health, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
4Department of Physiology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA
5The Oklahoma Center for Neuroscience, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA

Received 1 March 2013; Accepted 22 May 2013

Academic Editor: Gail B. Mahady

Copyright © 2013 Tuan-Phat Huynh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. M. Cragg and D. J. Newman, “Biodiversity: a continuing source of novel drug leads,” Pure and Applied Chemistry, vol. 77, no. 1, pp. 7–24, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. D. A. Dias, S. Urban, and U. Roessner, “A historical overview of natural products in drug discovery,” Metabolites, vol. 2, no. 2, pp. 303–336, 2012. View at Publisher · View at Google Scholar
  3. A. Gurib-Fakim, “Medicinal plants: traditions of yesterday and drugs of tomorrow,” Molecular Aspects of Medicine, vol. 27, no. 1, pp. 1–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Quigley and A. T. Broman, “The number of people with glaucoma worldwide in 2010 and 2020,” The British Journal of Ophthalmology, vol. 90, no. 3, pp. 262–267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Klein, T. Peto, A. Bird, and M. R. Vannewkirk, “The epidemiology of age-related macular degeneration,” The American Journal of Ophthalmology, vol. 137, no. 3, pp. 486–495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. N. R. Farnsworth, O. Akerele, and A. S. Bingel, “Medicinal plants in therapy,” Bulletin of the World Health Organization, vol. 63, no. 6, pp. 965–981, 1985. View at Google Scholar · View at Scopus
  7. N. Congdon, J. R. Vingerling, B. E. Klein et al., “Prevalence of cataract and pseudophakia/aphakia among adults in the United States,” Archives of Ophthalmology, vol. 122, no. 4, pp. 487–494, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. H. Kempen, B. J. O'Colmain, M. C. Leske et al., “The prevalence of diabetic retinopathy among adults in the United States,” Archives of Ophthalmology, vol. 122, no. 4, pp. 552–563, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. J. K. Shen, A. Dong, S. F. Hackett, W. R. Bell, W. R. Green, and P. A. Campochiaro, “Oxidative damage in age-related macular degenration,” Histology and Histopathology, vol. 22, no. 12, pp. 1301–1308, 2007. View at Google Scholar
  10. J. G. Hollyfield, V. L. Bonilha, M. E. Rayborn et al., “Oxidative damage-induced inflammation initiates age-related macular degeneration,” Nature Medicine, vol. 14, no. 2, pp. 194–198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. L. A. Donoso, D. Kim, A. Frost, A. Callahan, and G. Hageman, “The role of inflammation in the pathogenesis of age-related macular degeneration,” Survey of Ophthalmology, vol. 51, no. 2, pp. 137–152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. Age-Related Eye Disease Study Research Group, “A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, β carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8,” Archives of Ophthalmology, vol. 119, no. 10, pp. 1417–1436, 2008. View at Google Scholar
  13. AREDS2 Research Group, E. Y. Chew, T. Clemons et al., “The age-related eye sisease study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1),” Ophtalmology, vol. 119, no. 11, pp. 2282–2289, 2012. View at Publisher · View at Google Scholar
  14. D. R. Anderson, “The optic nerve in glaucoma,” in Duane’s Ophthalmology, W. Tasman and E. A. Jaeger, Eds., Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2009. View at Google Scholar
  15. R. Ritch, “Natural compounds: evidence for a protective role in eye disease,” Canadian Journal of Ophthalmology, vol. 42, no. 3, pp. 425–438, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Mandelcorn and N. Gupta, “Lens-related glaucomas,” in Duane’s Ophthalmology, W. Tasman and E. A. Jaeger, Eds., Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2009. View at Google Scholar
  17. J. W. Y. Yau, S. L. Rogers, R. Kawasaki et al., “Global prevalence and major risk factors of diabetic retinopathy,” Diabetes Care, vol. 35, no. 3, pp. 556–564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. D. S. Fong, L. Aiello, T. W. Gardner et al., “Diabetic retinopathy,” Diabetes Care, vol. 26, no. 1, pp. S99–S102, 2003. View at Google Scholar · View at Scopus
  19. P. A. Sieving and R. C. Caruso, “Retinitis pigmentosa and related disorders,” in Ophthalmology, M. Yanoff and J. S. Duker, Eds., Mosby Elsevier, Maryland Heights, Mo, USA, 2008. View at Google Scholar
  20. R. A. Radu, Q. Yuan, J. Hu et al., “Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following vitamin A supplementation,” Investigative Ophthalmology and Visual Science, vol. 49, no. 9, pp. 3821–3829, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. J. S. Zigler Jr. and M. B. Datiles III, “Pathogenesis of cataracts,” in Duane's Ophthalmology, W. Tasman and E. A. Jaeger, Eds., Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2011. View at Google Scholar
  22. G. Brian and H. Taylor, “Cataract blindness—challenges for the 21st century,” Bulletin of the World Health Organization, vol. 79, no. 3, pp. 249–256, 2001. View at Google Scholar · View at Scopus
  23. J. C. Tilak, M. Banerjee, H. Mohan, and T. P. A. Devasagayam, “Antioxidant availability of turmeric in relation to its medicinal and culinary uses,” Phytotherapy Research, vol. 18, no. 10, pp. 798–804, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. B. B. Aggarwal, A. Kumar, and A. C. Bharti, “Anticancer potential of curcumin: preclinical and clinical studies,” Anticancer Research, vol. 23, no. 1, pp. 363–398, 2003. View at Google Scholar · View at Scopus
  25. Y. Wang, M. Pan, A. Cheng et al., “Stability of curcumin in buffer solutions and characterization of its degradation products,” Journal of Pharmaceutical and Biomedical Analysis, vol. 15, no. 12, pp. 1867–1876, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Goel, A. B. Kunnumakkara, and B. B. Aggarwal, “Curcumin as “Curecumin”: from kitchen to clinic,” Biochemical Pharmacology, vol. 75, no. 4, pp. 787–809, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Abe, S. Hashimoto, and T. Horie, “Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages,” Pharmacological Research, vol. 39, no. 1, pp. 41–47, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. M. N. A. Mandal, J. M. R. Patlolla, L. Zheng et al., “Curcumin protects retinal cells from light-and oxidant stress-induced cell death,” Free Radical Biology and Medicine, vol. 46, no. 5, pp. 672–679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Woo, D. Y. Shin, S. J. Lee et al., “Curcumin protects retinal pigment epithelial cells against oxidative stress via induction of heme oxygenase-1 expression and reduction of reactive oxygen,” Molecular Vision, vol. 18, pp. 901–908, 2012. View at Google Scholar
  30. S. K. Gupta, B. Kumar, T. C. Nag et al., “Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms,” Journal of Ocular Pharmacology and Therapeutics, vol. 27, no. 2, pp. 123–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Suryanarayana, M. Saraswat, T. Mrudula, T. P. Krishna, K. Krishnaswamy, and G. B. Reddy, “Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats,” Investigative Ophthalmology and Visual Science, vol. 46, no. 6, pp. 2092–2099, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. T. N. Raju, C. S. Kumar, V. R. Kanth et al., “Cumulative antioxidant defense against oxidative challenge in galactose-induced cataractogenesis in Wistar rats,” Indian Journal of Experimental Biology, vol. 44, no. 9, pp. 733–739, 2006. View at Google Scholar · View at Scopus
  33. U. Pandya, M. K. Saini, G. F. Jin, S. Awasthi, B. F. Godley, and Y. C. Awasthi, “Dietary curcumin prevents ocular toxicity of naphthalene in rats,” Toxicology Letters, vol. 115, no. 3, pp. 195–204, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Manikandan, R. Thiagarajan, S. Beulaja, G. Sudhandiran, and M. Arumugam, “Effect of curcumin on selenite-induced cataractogenesis in wistar rat pups,” Current Eye Research, vol. 35, no. 2, pp. 122–129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. P. A. Kumar, P. Suryanarayana, P. Y. Reddy, and G. B. Reddy, “Modulation of α-crystallin chaperone activity in diabetic rat lens by curcumin,” Molecular Vision, vol. 11, pp. 561–568, 2005. View at Google Scholar · View at Scopus
  36. C. E. Goodpasture and F. E. Arrighi, “Effect of food seasoning on the cell cycle and chromosome morphology of mammalian cells in vitro with special reference to turmeric,” Food and Cosmetics Toxicology, vol. 14, no. 1, pp. 9–14, 1976. View at Google Scholar · View at Scopus
  37. A. K. Giri, S. K. Das, G. Talukder, and A. Sharma, “Sister chromatid exchange and chromosome aberrations induced by curcumin and tartrazine on mammalian cells in vivo,” Cytobios, vol. 62, no. 249, pp. 111–117, 1990. View at Google Scholar · View at Scopus
  38. H. Ahsan and S. M. Hadi, “Strand scission in DNA induced by curcumin in the presence of Cu(II),” Cancer Letters, vol. 124, no. 1, pp. 23–30, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Sakano and S. Kawanishi, “Metal-mediated DNA damage induced by curcumin in the presence of human cytochrome P450 isozymes,” Archives of Biochemistry and Biophysics, vol. 405, no. 2, pp. 223–230, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Nair, S. Strand, N. Frank et al., “Apoptosis and age-dependant induction of nuclear and mitochondrial etheno-DNA adducts in long-evans cinnamon (LEC) rats: enhanced DNA damage by dietary curcumin upon copper accumulation,” Carcinogenesis, vol. 26, no. 7, pp. 1307–1315, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Blasiak, A. Trzeciak, and J. Kowalik, “Curcumin damages DNA in human gastric mucosa cells and lymphocytes,” Journal of Environmental Pathology, Toxicology and Oncology, vol. 18, no. 4, pp. 271–276, 1999. View at Google Scholar · View at Scopus
  42. M. R. Kelly, J. Xu, K. E. Alexander, and G. Loo, “Disparate effects of similar phenolic phytochemicals as inhibitors of oxidative damage to cellular DNA,” Mutation Research—DNA Repair, vol. 485, no. 4, pp. 309–318, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Cao, L. Jia, H. Zhou, Y. Liu, and L. Zhong, “Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells,” Toxicological Sciences, vol. 91, no. 2, pp. 476–483, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Urbina-Cano, L. Bobadilla-Morales, M. A. Ramírez-Herrera et al., “DNA damage in mouse lymphocytes exposed to curcumin and copper,” Journal of Applied Genetics, vol. 47, no. 4, pp. 377–382, 2006. View at Google Scholar · View at Scopus
  45. R. D. Verschoyle, W. P. Steward, and A. J. Gescher, “Putative cancer chemopreventive agents of dietary origin—how safe are they?” Nutrition and Cancer, vol. 59, no. 2, pp. 152–162, 2007. View at Google Scholar · View at Scopus
  46. E. Burgos-Morón, J. M. Calderón-Montaño, J. Salvador, A. Robles, and M. López-Lázaro, “The dark side of curcumin,” International Journal of Cancer, vol. 126, no. 7, pp. 1771–1775, 2009. View at Publisher · View at Google Scholar
  47. O. Sommerburg, J. E. E. Keunen, A. C. Bird, and F. J. G. M. van Kuijk, “Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes,” The British Journal of Ophthalmology, vol. 82, no. 8, pp. 907–910, 1998. View at Google Scholar · View at Scopus
  48. Eye Disease Case-Control Study Group, “Antioxidant status and neovascular age-related macular degeneration,” Archives of Ophthalmology, vol. 111, no. 1, pp. 104–109, 1993. View at Publisher · View at Google Scholar
  49. N. I. Krinsky, J. T. Landrum, and R. A. Bone, “Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye,” Annual Review of Nutrition, vol. 23, pp. 171–201, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. G. Haegerstrom-Portnoy, “Short-wavelength-sensitive-cone sensitivity loss with aging: a protective role for macular pigment?” Journal of the Optical Society of America A, vol. 5, no. 12, pp. 2140–2144, 1988. View at Google Scholar · View at Scopus
  51. Q. Bian, S. Gao, J. Zhou et al., “Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells,” Free Radical Biology and Medicine, vol. 53, no. 6, pp. 1298–1307, 2012. View at Publisher · View at Google Scholar
  52. Q. Bian, T. Qin, Z. Ren, D. Wu, and F. Shang, “Lutein or zeaxanthin supplementation suppresses inflammatory responses in retinal pigment epithelial cells and macrophages,” Advances in Experimental Medicine and Biology, vol. 723, pp. 43–50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Ma, S. F. Yan, Y. M. Huang et al., “Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration,” Ophtalmology, vol. 119, no. 11, pp. 2290–2297, 2012. View at Publisher · View at Google Scholar
  54. L. Ma, H. L. Dou, Y. M. Huang et al., “Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial,” The American Journal of Ophthalmology, vol. 154, no. 4, pp. 625–634, 2012. View at Publisher · View at Google Scholar
  55. S. P. Richer, W. Stiles, K. Graham-Hoffman et al., “Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the zeaxanthin and visual function study (ZVF) FDA IND #78, 973,” Optometry, vol. 82, no. 11, pp. 667.e6–680.e6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. R. A. Bone, J. T. Landrum, L. H. Guerra, and C. A. Ruiz, “Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentations of these carotenoids in humans,” Journal of Nutrition, vol. 133, no. 4, pp. 992–998, 2003. View at Google Scholar
  57. O. E. Makri, A. Ferlemi, F.N. Lamari, and C.D. Georgakopoulos, “Effect of Crocus sativus stigmas (saffron) extract on sodium selenite induced cataract formation,” Acta Ophthalmologica, vol. 90, article s249, 2012. View at Publisher · View at Google Scholar
  58. B. Falsini, M. Piccardi, A. Minnella et al., “Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 51, no. 12, pp. 6118–6124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. A. F. Alex, M. Spitznas, A. P. Tittel, C. Kurts, and N. Eter, “Inhibitory effect of epigallocatechin gallate (EGCG), resveratrol, and curcumin on proliferation of human retinal pigment epithelial cells in vitro,” Current Eye Research, vol. 35, no. 11, pp. 1021–1033, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Chan, J. Huang, H. Chiang et al., “Effects of (-)-epigallocatechin gallate on rpe cell migration and adhesion,” Molecular Vision, vol. 16, pp. 586–595, 2010. View at Google Scholar · View at Scopus
  61. S. M. Lee, I. Ko, S. Kim, D. H. Kim, and B. N. Kang, “Protective effect of catechin on apoptosis of the lens epithelium in rats with N-methyl-N-nitrosourea-induced cataracts,” Korean Journal of Ophthalmology, vol. 24, no. 2, pp. 101–107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. K. M. Maclennan, C. L. Darlington, and P. F. Smith, “The CNS effects of Ginkgo biloba extracts and ginkgolide B,” Progress in Neurobiology, vol. 67, no. 3, pp. 235–257, 2002. View at Publisher · View at Google Scholar · View at Scopus
  63. N. R. Kim, J. H. Kim, and C. Y. Kim, “Efect of Korean red ginseng supplementation on ocular blood flow in patients with glaucoma,” Journal of Ginseng Research, vol. 34, no. 3, pp. 237–245, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Y. Cho, E. S. Yoo, K. U. Baik, M. H. Park, and B. H. Han, “In vitro inhibitory effect of protopanaxadiol ginsenosides on tumor necrosis factor (TNF)-α production and its modulation by known TNF-α antagonists,” Planta Medica, vol. 67, no. 3, pp. 213–218, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Sen, S. Chen, Y. Wu, B. Feng, E. K. Lui, and S. Chakrabarti, “Preventive effects of North American ginseng (Panax quinquefolius) on diabetic retinopathy and cardiomyopathy,” Phytotherapy Research, vol. 27, no. 2, pp. 290–298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. S. M. Lee, J. M. Sun, J. H. Jeong et al., “Analysis of the effective fraction of sun ginseng extract in selenite induced cataract rat model,” Journal of the Korean Ophthalmological Society, vol. 51, pp. 733–739, 2010. View at Google Scholar
  67. N. N. Osborne, “Pathogenesis of ganglion “cell death” in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria,” Progress in Brain Research, vol. 173, pp. 339–352, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. C. Li, L. Wang, K. Huang, and L. Zheng, “Endoplasmic reticulum stress in retinal vascular degeneration: protective role of resveratrol,” Investigative Ophthalmology and Visual Science, vol. 53, no. 6, pp. 3241–3249, 2012. View at Publisher · View at Google Scholar
  69. T. L. Kwok, R. Y. Y. Chiou, G. C. Li et al., “Neuroprotective effects of resveratrol on cerebral ischemia-induced neuron loss mediated by free radical scavenging and cerebral blood flow elevation,” Journal of Agricultural and Food Chemistry, vol. 54, no. 8, pp. 3126–3131, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. G. A. Losa, “Resveratrol modulates apoptosis and oxidation in human blood mononuclear cells,” European Journal of Clinical Investigation, vol. 33, no. 9, pp. 818–823, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. A. S. Yar, S. Menevse, I. Dogan et al., “Investigation of ocular neovascularization-related genes and oxidative stress in diabetic rat eye tissues after resveratrol treatment,” Journal of Medicinal Food, vol. 15, no. 4, pp. 391–398, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. H. Kim, Y. S. Kim, G. S. Roh, W. S. Choi, and G. J. Cho, “Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas,” Acta Ophthalmologica, vol. 90, no. 1, pp. e31–e37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. J. Hua, K. I. Guerin, J. Chen et al., “Resveratrol inhibits pathologic retinal neovascularization in Vldlr-/- mice,” Investigative Ophthalmology and Visual Science, vol. 52, no. 5, pp. 2809–2816, 2011. View at Publisher · View at Google Scholar · View at Scopus
  74. N. N. Osborne, R. J. Casson, J. P. M. Wood, G. Chidlow, M. Graham, and J. Melena, “Retinal ischemia: mechanisms of damage and potential therapeutic strategies,” Progress in Retinal and Eye Research, vol. 23, no. 1, pp. 91–147, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Zhu and F. Cai, “Evidence of compromised circulation in the pathogenesis of optic nerve damage in chronic glaucomatous rabbit,” Chinese Medical Journal, vol. 106, no. 12, pp. 922–927, 1993. View at Google Scholar · View at Scopus
  76. Z. Z. Wu, J. Y. Jiang, Y. M. Yi, and M. T. Xia, “Radix salviae miltiorrhizae in middle and late stage glaucoma,” Chinese Medical Journal, vol. 96, no. 6, pp. 445–447, 1983. View at Google Scholar · View at Scopus
  77. L. Zhang, S. Z. Dai, X. D. Nie, L. Zhu, F. Xing, and L. Y. Wang, “Effect of Salvia miltiorrhiza on retinopathy,” Asian Pacific Journal of Tropical Medicine, vol. 6, no. 2, pp. 145–149, 2013. View at Publisher · View at Google Scholar
  78. Y. Chen, X. Li, N. Xing, and X. Cao, “Quercetin inhibits choroidal and retinal angiogenesis in vitro,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 246, no. 3, pp. 373–378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Stefek and C. Karasu, “Eye lens in aging and diabetes: effect of quercetin,” Rejuvenation Research, vol. 14, no. 5, pp. 525–534, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. A. K. Shetty, R. Rashmi, M. G. R. Rajan, K. Sambaiah, and P. V. Salimath, “Antidiabetic influence of quercetin in streptozotocin-induced diabetic rats,” Nutrition Research, vol. 24, no. 5, pp. 373–381, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. R. N. Gacche and N. A. Dhole, “Profile of aldose reductase inhibition, anti-cataract and free radical scavenging activity of selected medicinal plants: an attempt to standardize the botanicals for amelioration of diabetes complications,” Food and Chemical Toxicology, vol. 49, no. 8, pp. 1806–1813, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Giaccio, “Crocetin from saffron: an active component of an ancient spice,” Critical Reviews in Food Science and Nutrition, vol. 44, no. 3, pp. 155–172, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Soeda, T. Ochiai, L. Paopong, H. Tanaka, Y. Shoyama, and H. Shimeno, “Crocin suppresses tumor necrosis factor-α-induced cell death of neuronally differentiated PC-12 cells,” Life Sciences, vol. 69, no. 24, pp. 2887–2898, 2001. View at Publisher · View at Google Scholar · View at Scopus
  84. R. Maccarone, S. Di Marco, and S. Bisti, “Saffron supplement maintains morphology and function after exposure to damaging light in mammalian retina,” Investigative Ophthalmology and Visual Science, vol. 49, no. 3, pp. 1254–1261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. T. Ochiai, S. Soeda, S. Ohno, H. Tanaka, Y. Shoyama, and H. Shimeno, “Crocin prevents the death of PC-12 cells through sphingomyelinase-ceramide signaling by increasing glutathione synthesis,” Neurochemistry International, vol. 44, no. 5, pp. 321–330, 2004. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Yamauchi, K. Tsuruma, S. Imai et al., “Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity,” European Journal of Pharmacology, vol. 650, no. 1, pp. 110–119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Lee, K. Im, S. Suh, and J. Jung, “Protective effect of green tea polyphenol (-)-epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates,” Phytotherapy Research, vol. 17, no. 3, pp. 206–209, 2003. View at Publisher · View at Google Scholar · View at Scopus
  88. J. V. Higdon and B. Frei, “Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions,” Critical Reviews in Food Science and Nutrition, vol. 43, no. 1, pp. 89–143, 2003. View at Publisher · View at Google Scholar · View at Scopus
  89. B. Zhang and N. N. Osborne, “Oxidative-induced retinal degeneration is attenuated by epigallocatechin gallate,” Brain Research, vol. 1124, no. 1, pp. 176–187, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. A. W. Siu, M. K. Lau, J. S. Cheng et al., “Glutamate-induced retinal lipid and protein damage: the protective effects of catechin,” Neuroscience Letters, vol. 432, no. 3, pp. 193–197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. B. Zhang, D. Rusciano, and N. N. Osborne, “Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro,” Brain Research, vol. 1198, pp. 141–152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. B. L. D. S. A. D. Costa, R. Fawcett, G. Li, R. Safa, and N. N. Osborne, “Orally administered epigallocatechin gallate attenuates light-induced photoreceptor damage,” Brain Research Bulletin, vol. 76, no. 4, pp. 412–423, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. D. Janssens, E. Delaive, J. Remacle, and C. Michiels, “Protection by bilobalide of the ischaemia-induced alterations of the mitochondrial respiratory activity,” Fundamental and Clinical Pharmacology, vol. 14, no. 3, pp. 193–201, 2000. View at Google Scholar · View at Scopus
  94. S. Pierr, I. Jamme, K. Robert et al., “Ginkgo biloba extract (EGb 761) protects Na, K-ATPase isoenzymes during cerevral ischemia,” Cell and Molecular Biology, vol. 48, no. 6, pp. 671–680, 2002. View at Google Scholar
  95. J. Sastre, A. Lloret, C. Borrás et al., “Ginkgo biloba extract EGb 761 protects against mitochondrial aging in the brain and in the liver,” Cell and Molecular Biology, vol. 48, no. 6, pp. 685–692, 2002. View at Google Scholar
  96. L. Marcocci, J. J. Maguire, M. T. Droy-Lefaix, and L. Packer, “The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761,” Biochemical and Biophysical Research Communications, vol. 201, no. 2, pp. 748–755, 1994. View at Publisher · View at Google Scholar · View at Scopus
  97. K. Ma, L. Xu, H. Zhang, S. Zhang, M. Pu, and J. B. Jonas, “The effect of ginkgo biloba on the rat retinal ganglion cell survival in the optic nerve crush model,” Acta Ophthalmologica, vol. 88, no. 5, pp. 553–557, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. Q. H. Qiu, Z. G. Xie, X. Xu, S. X. Liang, and Y. Gao, “EGB761 on retinal light injury in rats,” Chinese Medical Journal, vol. 125, no. 13, pp. 2306–2309, 2012. View at Google Scholar
  99. A. K. Cybulska-Heinrich, M. Mozaffarieh, and J. Flammer, “Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma,” Molecular Vision, vol. 18, pp. 390–402, 2012. View at Google Scholar · View at Scopus
  100. A. A. Izzo, “Interactions between herbs and conventional drugs: overview of the clinical data,” Medical Principles and Practice, vol. 21, no. 5, pp. 404–428, 2012. View at Publisher · View at Google Scholar · View at Scopus
  101. A. S. Attele, J. A. Wu, and C. Yuan, “Ginseng pharmacology: multiple constituents and multiple actions,” Biochemical Pharmacology, vol. 58, no. 11, pp. 1685–1693, 1999. View at Publisher · View at Google Scholar · View at Scopus
  102. Y. C. Kim, S. R. Kim, G. J. Markelonis, and T. H. Oh, “Ginsenosides Rb1 and Rg3 protect cultured rat cortical cells from glutamate-induced neurodegeneration,” Journal of Neuroscience Research, vol. 53, no. 4, pp. 426–432, 1998. View at Google Scholar
  103. S. Kim, K. Ahn, T. H. Oh, S. Nah, and H. Rhim, “Inhibitory effect of ginsenosides on NMDA receptor-mediated signals in rat hippocampal neurons,” Biochemical and Biophysical Research Communications, vol. 296, no. 2, pp. 247–254, 2002. View at Publisher · View at Google Scholar · View at Scopus
  104. Y. Xiong, L. Shen, K. J. Liu et al., “Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats,” Diabetes, vol. 59, no. 10, pp. 2505–2512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. W. Lee, S. T. Kao, I. M. Liu, and J. T. Cheng, “Increase of insulin secretion by ginsenoside Rh2 to lower plasma glucose in Wistar rats,” Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 1-2, pp. 27–32, 2006. View at Publisher · View at Google Scholar · View at Scopus
  106. J. Z. Luo and L. Luo, “American ginseng stimulates insulin production and prevents apoptosis through regulation of uncoupling protein-2 in cultured β cells,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 3, pp. 365–372, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. P. Pignatelli, F. M. Pulcinelli, A. Celestini et al., “The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide,” The American Journal of Clinical Nutrition, vol. 72, no. 5, pp. 1150–1155, 2000. View at Google Scholar · View at Scopus
  108. P. Russo, I. Tedesco, M. Russo, G. L. Russo, A. Venezia, and C. Cicala, “Effects of de-alcoholated red wine and its phenolic fractions on platelet aggregation,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 11, no. 1, pp. 25–29, 2001. View at Google Scholar · View at Scopus
  109. P. R. Slane, A. A. Qureshi, and J. D. Folts, “Platelet inhibition in stenosed canine arteries by quercetin and rutin, polyphenolic flavonoids found in red wine,” Clinical Research, vol. 42, article A162, 1994. View at Google Scholar
  110. R. Corder, J. A. Douthwaite, D. M. Lees et al., “Endothelin-1 synthesis red wine,” Nature, vol. 414, no. 6866, pp. 863–864, 2001. View at Publisher · View at Google Scholar · View at Scopus
  111. J. A. Baur, K. J. Pearson, N. L. Price et al., “Resveratrol improves health and survival of mice on a high-calorie diet,” Nature, vol. 444, no. 7117, pp. 337–342, 2006. View at Publisher · View at Google Scholar · View at Scopus
  112. S. Chanvitayapongs, B. Draczynska-Lusiak, and A. Y. Sun, “Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells,” NeuroReport, vol. 8, no. 6, pp. 1499–1502, 1997. View at Google Scholar · View at Scopus
  113. E. N. Frankel, A. L. Waterhouse, and J. E. Kinsella, “Inhibition of human LDL oxidation by resveratrol,” The Lancet, vol. 341, no. 8852, pp. 1103–1104, 1993. View at Google Scholar · View at Scopus
  114. S. Shigematsu, S. Ishida, M. Hara et al., “Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants,” Free Radical Biology and Medicine, vol. 34, no. 7, pp. 810–817, 2003. View at Publisher · View at Google Scholar · View at Scopus
  115. H. Zhuang, Y. Kim, R. C. Koehler, and S. Doré, “Potential mechanism by which resveratrol, a red wine constituent, protects neurons,” Annals of the New York Academy of Sciences, vol. 993, pp. 276–286, 2003. View at Google Scholar · View at Scopus
  116. S. Doganay, M. Borazan, M. Iraz, and Y. Cigremis, “The effect of resveratrol in experimental cataract model formed by sodium selenite,” Current Eye Research, vol. 31, no. 2, pp. 147–153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. Y. Chen, S. Lin, H. Ku et al., “Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-α-treated human aortic endothelial cells,” Journal of Cellular Biochemistry, vol. 82, no. 3, pp. 512–521, 2001. View at Publisher · View at Google Scholar · View at Scopus
  118. Y. Wu, C. Hong, S. Lin, P. Wu, and M. Shiao, “Increase of vitamin e content in LDL and reduction of atherosclerosis in cholesterol-fed rabbits by a water-soluble antioxidant-rich fraction of Salvia miltiorrhiza,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 3, pp. 481–486, 1998. View at Google Scholar · View at Scopus
  119. X. Sun, L. N. Chan, X. Gong, and N. J. Sucher, “N-methyl-D-aspartate receptor antagonist activity in traditional chinese stroke medicines,” NeuroSignals, vol. 12, no. 1, pp. 31–38, 2003. View at Publisher · View at Google Scholar · View at Scopus
  120. S. Bhagwat, D. B. Haytowitz, and J. M. Holden, USDA Database for the Flavonoid Content of Selected Foods, United States Department of Agriculture, 2011.
  121. J. V. Formica and W. Regelson, “Review of the biology of quercetin and related bioflavonoids,” Food and Chemical Toxicology, vol. 33, no. 12, pp. 1061–1080, 1995. View at Publisher · View at Google Scholar · View at Scopus
  122. L. K. Stewart, J. L. Soileau, D. Ribnicky et al., “Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet,” Metabolism, vol. 57, no. 1, pp. S39–S46, 2008. View at Publisher · View at Google Scholar · View at Scopus
  123. X. Cao, M. Liu, J. Tuo, D. Shen, and C. Chan, “The effects of quercetin in cultured human RPE cells under oxidative stress and in Ccl2/Cx3cr1 double deficient mice,” Experimental Eye Research, vol. 91, no. 1, pp. 15–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  124. D. Kook, A. H. Wolf, A. L. Yu et al., “The protective effect of quercetin against oxidative stress in the human RPE in vitro,” Investigative Ophthalmology and Visual Science, vol. 49, no. 4, pp. 1712–1720, 2008. View at Publisher · View at Google Scholar · View at Scopus
  125. F. M. Areias, A. C. Rego, C. R. Oliveira, and R. M. Seabra, “Antioxidant effect of flavonoids after ascorbate/Fe2+-induced oxidative stress in cultured retinal cells,” Biochemical Pharmacology, vol. 62, no. 1, pp. 111–118, 2001. View at Publisher · View at Google Scholar · View at Scopus
  126. P. Zhuang, Y. Shen, B. Q. Lin, W. Y. Zhang, and G. C. Chiou, “Effect of quercetin on formation of chrooidal neovascularization (CNV) in age-related macular degeneration (AMD),” Eye Science, vol. 26, no. 1, pp. 23–29, 2011. View at Publisher · View at Google Scholar
  127. Y. Ishii, J. M. K. Kwong, and J. Caprioli, “Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model,” Investigative Ophthalmology and Visual Science, vol. 44, no. 5, pp. 1982–1992, 2003. View at Publisher · View at Google Scholar · View at Scopus
  128. D. W. Lamson and M. S. Brignall, “Antioxidants and cancer III: quercetin,” Alternative Medicine Review, vol. 5, no. 3, pp. 196–208, 2000. View at Google Scholar · View at Scopus
  129. A. W. Boots, G. R. M. M. Haenen, and A. Bast, “Health effects of quercetin: from antioxidant to nutraceutical,” European Journal of Pharmacology, vol. 585, no. 2-3, pp. 325–337, 2008. View at Publisher · View at Google Scholar · View at Scopus